Allergy Therapeutics Share Discussion Threads

[audigger] 27/6/2019 10:50

Didn't see that coming. Certainly reinforces the belief that the management team are on top of things. Proving to be a bit of a roller coaster ride this year! What would be impressive is if they can pull a rabbit out of the hat with a more favourable interpretation of the B301 Phase III trial for the birch product.

[ewanwhose] 27/6/2019 08:03

Plenty of cash and can we dare hope for a bottom-line profit?

[jimmyloser] 27/6/2019 07:15

Breaking news



Allergy Therapeutics plc

("Allergy Therapeutics", "ATL" or the "Group")



Successful litigation settlement relating to PQ Grass Phase II Trial



27 June 2019 Allergy Therapeutics plc (AIM: AGY), the fully integrated commercial biotechnology company specialising in allergy vaccines, announces that it has received a $7.6m settlement from Inflamax Research Inc. ("Inflamax") in relation to legal proceedings about the previously disclosed inconclusive Phase II Grass MATA MPL trial which took place in the USA in 2015-16. Inflamax has also agreed to pay a substantial part of the Group's legal costs.



The clinical trial (G204) used mobile challenge chambers provided by Inflamax and preceded the successful Grass MATA MPL trial (G205) which the Group reported in June 2018. The Group commenced legal proceedings in the English High Court against Inflamax in March 2017 for breach of contract and misrepresentation concerning the G204 Study.



Commenting on outcome, Manuel Llobet, CEO of Allergy Therapeutics, said: "ATL has always had full confidence in the Grass MATA MPL product and maintained that the inconclusive results of the G204 study were due to the inadequate procedures in the study. I am pleased that Inflamax have now compensated ATL for a significant proportion of the wasted study costs, as well as agreeing to pay the majority of the legal costs. Allergy Therapeutics aims to maintain the highest standards throughout its business and we are pleased that the matter has now been resolved."

[ewanwhose] 25/6/2019 11:25

About time Skygem topped up.

[jimmyloser] 14/6/2019 08:19

On Thursday Liu Xiaoming, China's ambassador to the UK, said that excluding Huawei from Britain's 5G network would "send a very bad signal".

However, weak sterling gives Chinese investors an opportunity to buy more UK assets, says Monique Wong of Coutts.

Chinese investment in the UK has largely been focused on the commercial property sector - "the iconic Cheesegrater was sold to Chinese investors a couple of years ago for just over a billion pounds", she says.

"And don't forgot sterling is cheap, " she said, about 10% cheaper against the Chinese currency since the referendum.

"It is an opportunity for Chinese investors and international investors more broadly," she said, adding that China's Fosun has expressed an interest in buying Thomas Cook's tour business.

She also had a view on why was the market impact of the Hong Kong protests was limited - the Hang Seng stock index was down less than 0.5%.

She said: "Usually the protests blow over... it doesn't really change our view on the region".

[andrewbaker] 11/6/2019 13:45

@jimmyloser Is Woodford buying in?

If he was, the price would nosedive: maybe he's shorting it?

[jimmyloser] 11/6/2019 07:03

See above......Somebody likes the taste of peanuts.

15% of AGY for circa 11p a share !!!

[jimmyloser] 07/6/2019 10:49

Here we go again....are the Chinese investors looking for more than peanuts?

[jimmyloser] 06/6/2019 11:07

Chinese peanuts!

[nquaile875] 05/6/2019 17:35

Well done Jimmy, very funny!!! :-)

[jimmyloser] 05/6/2019 15:46

Is Woodford buying in?

[jimmyloser] 03/6/2019 19:19

A few positive words on peanuts over the next few days would not go amiss.

[ewanwhose] 03/6/2019 12:39

Good to see some buying today. Can't see any news anywhere.

[audigger] 20/5/2019 07:22

Indeed thew mention of China appears a new line form the PR gurus they employ. Encouraging but early days yet and we know how perilous the journey can be. Would be good if it gave the share price another small jolt north

[jimmyloser] 20/5/2019 07:06

A little encouraging news this morning from AGY and am I alone in noting the CHINA gets a first mention as a potential market?

[blather1] 15/5/2019 13:41

Hmm....I wonder what is going on? Wonder what the detailed history is of ZQ investments internationally over time?

[ewanwhose] 15/5/2019 13:24

There is a hierarchy of ZQ companies who own a hierarchy of Skygem companies - they are listed in the RNS

[blather1] 15/5/2019 13:16

So a total of close to 30% of all AGY shares were snapped up in three (think it was three) momentous buys on one day and only part of those trades were accounted for by ZQ as mentioned in the RNS. Is Skygem and ZQ the same entity?

[ewanwhose] 15/5/2019 12:32

I've been wondering this as well. 500M shares were traded (ie 250M bought and 250M sold). Skygem declared ~76M. In the absence of another declaration, it would seem that all the shares bought by Skygem were bought by another entity (not a MM) and passed on the same day. It could be a way of hiding the true purchaser, somebody taking a cut or somebody wanting to bump up their trading volumes.

[ewanwhose] 15/5/2019 12:24

Skygem Acquisitions is a subsidiary of Skygem Holdings and the only thing it has done is buy AGY shares. The name just seems a bit too obvious - do they really plan to 'acquire' all of AGY or just make it look like they want to?

[blather1] 15/5/2019 09:58

Not sure what you mean Ewanwhose....”clue or bluff”. I do get confused by the cryptic or jargonesque comments on here. Back to the ZQ acquisition which has resulted in them owning 12% of AGY . The total expenditure on the big £million plus buys the other day was close to £20 million. The AGY NAV at the time was £70 million or so. If it was one buyer , a spend of £20 million results in a holding of nearly 30% (seem to remember it was close to 200 million shares that were bought in the big transactions)! So who bought the other 18% of the total shares? Who was buying in concert with ZQ .....existing shareholders or new ones? Are we due another RNS?

[ewanwhose] 14/5/2019 09:32

... and is 'Skygem Acquisition' a clue or a bluff?

[blather1] 14/5/2019 09:29

....and of course the Angiotech deal was a full takeover....100%!

[ewanwhose] 14/5/2019 09:27

If you look at the RNS, it lists ZQ as the ultimate corporate owner (with Shen owning that). Simple Google will do you the rest.AFAICS, the active holding company in the group is Vivo Capital, which claims to have $2.2bn investments and a string of biotech companies. So this appears to be a knowledgeable biotech organisation, not just an opportunist investor. Market not impressed, so far at least.

[blather1] 14/5/2019 09:26

Here’s another pharma purchase by ZQ and others in 2016.

hxxps://www.prnewswire.com/news-releases/vivo-capital-and-zq-capital-limited-enter-into-an-agreement-to-acquire-angiotech-pharmaceuticals-300380542.html

If , as is claimed , that the investment by ZQ is to facilitate business/entry in China of AGY products then that could be incredible news . China is just such a “developing country” of which I have written in earlier posts . A country which is adopting western ways which are known to amplify and even cause some allergy symptoms. It’s also a huge market and a big commercial commitment by Chinese investors is likely to oil the wheels of doing business there. I wonder....do AGY do any business in China now?